291 related articles for article (PubMed ID: 23910561)
41. [Positron emission tomography in the diagnosis and monitoring of patients with nonseminomatous germ cell tumours].
Büchler T; Simonová K; Fencl P; Abrahámová J
Klin Onkol; 2011; 24(6):413-7. PubMed ID: 22257229
[TBL] [Abstract][Full Text] [Related]
42. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
[TBL] [Abstract][Full Text] [Related]
43. answer for the "Diagnosis and staging of solid pseudopapillary neoplasms of the pancreas: the role of 18 1 F-FDG PET/CT scan".
Wei J; Wang P; Chen Q; Miao Y
Pancreatology; 2018 Sep; 18(6):689. PubMed ID: 29937363
[No Abstract] [Full Text] [Related]
44.
Chambers G; Frood R; Patel C; Scarsbrook A
Br J Radiol; 2019 Feb; 92(1094):20180584. PubMed ID: 30383441
[TBL] [Abstract][Full Text] [Related]
45. Applications of positron emission tomography in neuro-oncology: a clinical approach.
Demetriades AK; Almeida AC; Bhangoo RS; Barrington SF
Surgeon; 2014 Jun; 12(3):148-57. PubMed ID: 24629841
[TBL] [Abstract][Full Text] [Related]
46. Diagnosis and staging of solid pseudopapillary neoplasms of the pancreas: The role of
Zizzo M; Manenti A; Lococo F; Pedrazzoli C
Pancreatology; 2018 Jun; 18(4):413-414. PubMed ID: 29459006
[No Abstract] [Full Text] [Related]
47. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
Shen B; Huang T; Sun Y; Jin Z; Li XF
Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
[TBL] [Abstract][Full Text] [Related]
48. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Delbeke D
J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
[TBL] [Abstract][Full Text] [Related]
49. Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.
Rizvi SN; Comans EF; Boellaard R; van Tinteren H; Hoekstra OS
Eur J Cancer; 2010 Aug; 46(12):2150-8. PubMed ID: 20561780
[TBL] [Abstract][Full Text] [Related]
50. Imaging Cancer Metabolism with Positron Emission Tomography (PET).
Witney TH; Lewis DY
Methods Mol Biol; 2019; 1928():29-44. PubMed ID: 30725448
[TBL] [Abstract][Full Text] [Related]
51. Non FDG PET.
Nanni C; Fantini L; Nicolini S; Fanti S
Clin Radiol; 2010 Jul; 65(7):536-48. PubMed ID: 20541653
[TBL] [Abstract][Full Text] [Related]
52. [Use of PET for evaluation of treatment response in oncology].
Bourguet P
Cancer Radiother; 2006 Nov; 10(6-7):334-7. PubMed ID: 16950641
[TBL] [Abstract][Full Text] [Related]
53. Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.
Pantaleo MA; Nannini M; Lopci E; Castellucci P; Maleddu A; Lodi F; Nanni C; Allegri V; Astorino M; Brandi G; Di Battista M; Boschi S; Fanti S; Biasco G
Int J Oncol; 2008 Sep; 33(3):443-52. PubMed ID: 18695872
[TBL] [Abstract][Full Text] [Related]
54. Clinical applications of PET in oncology.
Rohren EM; Turkington TG; Coleman RE
Radiology; 2004 May; 231(2):305-32. PubMed ID: 15044750
[TBL] [Abstract][Full Text] [Related]
55. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
Ak I; Stokkel MP; Pauwels EK
J Cancer Res Clin Oncol; 2000 Oct; 126(10):560-74. PubMed ID: 11043393
[TBL] [Abstract][Full Text] [Related]
56. PET imaging in endocrine tumours.
Khan S; Lloyd C; Szyszko T; Win Z; Rubello D; Al-Nahhas A
Minerva Endocrinol; 2008 Jun; 33(2):41-52. PubMed ID: 18414356
[TBL] [Abstract][Full Text] [Related]
57. [Positron emission tomography in neuroendocrine tumours].
Biermann M; Johnsen B; Sørbye H; Følling M; Sundin A; Bach-Gansmo T
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1474-7. PubMed ID: 19690598
[TBL] [Abstract][Full Text] [Related]
58. The role of nuclear medicine in the management of thymomas.
Treglia G; Spitilli MG; Calcagni ML; Giordano A
Ann Ital Chir; 2007; 78(5):371-4. PubMed ID: 18338540
[TBL] [Abstract][Full Text] [Related]
59. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose.
Shiue CY; Welch MJ
Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556
[TBL] [Abstract][Full Text] [Related]
60. Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences.
Coenen HH; Elsinga PH; Iwata R; Kilbourn MR; Pillai MR; Rajan MG; Wagner HN; Zaknun JJ
Nucl Med Biol; 2010 Oct; 37(7):727-40. PubMed ID: 20870148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
